NCT05127044View on ClinicalTrials.gov

Characterization of Pre-Term Neonatal Skin

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

August 17, 2024

Study Completion Date

August 17, 2024

Conditions
Skin Disorder
Interventions
DEVICE

Diffuse Reflectance Spectroscopy

DRS will be used as a non-invasive optical spectroscopy method to collect key biological information from neonatal skin including skin maturity, blood oxygenation, and bilirubin content.

DIAGNOSTIC_TEST

BiliChek

BiliChek will be used as a control for determining bilirubin content.

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT05127044 - Characterization of Pre-Term Neonatal Skin | Biotech Hunter | Biotech Hunter